drugset / Trial / NCT00346333

Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A

NCT00346333

Phase 3 Completed 240 enrolled National Eye Institute (NEI)
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to determine whether lutein in addition to vitamin A will slow the course of retinitis pigmentosa.

Timeline

Start
2003-07
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lutein Other / unclassified 12 mg

Indications